R-CHOP Versus R-FC Followed by Maintenance with Rituximab Versus Interferon-Alfa: Outcome of the First Randomized Trial for Elderly Patients with Mantle Cell Lymphoma

Konference: 2011 53rd ASH Annual Meeting – účast ČR

Kategorie: Maligní lymfomy a leukémie

Téma: 624. Lymphoma - Therapy with Biologic Agents, excluding Pre-Clinical Models: Mantle Cell and T Cell Lymphoma - Targeted Antibody and Small Molecule Approaches

Číslo abstraktu: 439

Autoři: Johanna C. Kluin-Nelemans; Eva Hoster; MD Jan Andrzej Walewski, Ph.D.; MD Stephan Stilgenbauer; MD Christian H. Geisler, PhD; MD Christian Gisselbrecht; MD Ursula Vehling-Kaiser; MD Jeanette K Doorduijn, PhD; Prof. MUDr. Marek Trněný, CSc.; MD Bertrand Coiffier; MD R. Forstpointner; MD Herve Tilly; MD Lothar Kanz; MD M. Szymczyk; Prof. Olivier Hermine, M.D., PhD; MD Wolfram Klapper, PhD; MD Wolfgang Hiddemann; MD Michael Unterhalt, PhD; MD Martin H. Dreyling, Ph.D.

Datum přednesení příspěvku: 12. 12. 2011